Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
FHTX
#3418
Foghorn Therapeutics Inc. Common Stock
4.860
0
USD
+0.21%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+0.21%
Changement Mensuel
-1.22%
Evolution sur 6 mois
+19.12%
Changement Annuel
+19.12%
Clôture Précédente
4.850
0
Open
4.835
0
Bid
Ask
Low
4.835
0
High
4.880
0
Volume
95
Marchés
Actions des Marchés US
Soins de Santé
FHTX
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
55.61 M
55.74 M
56.53 M
56.55 M
58.7 M
—
Valuation ratios
Enterprise value
207.04 M
142.43 M
193.12 M
187.2 M
236.11 M
758.86 M
Price to earnings ratio
-2.99
-2.83
-4.2
-4.61
-4.58
-16.22
Price to sales ratio
11.46
9.01
12.01
12.35
11
44.37
Price to cash flow ratio
-2.58
-2.2
-3.14
-3.35
-3.95
-12.64
Price to book ratio
-5.69
-1.44
-1.35
-1.1
-3.13
-7.02
Enterprise value to EBITDA ratio
-2.08
-1.51
-2.18
-2.25
-2.84
-8.78
Profitability ratios
Return on assets %
-0.07
-0.07
-0.08
-0.08
-0.11
-0.34
Return on equity %
0.43
0.31
0.23
0.18
0.2
0.92
Return on invested capital %
-42.46
—
—
—
-90.05
—
Gross margin %
100
100
100
100
100
400
Operating margin %
-840.51
-384.96
-279.17
-226.92
-258.22
-1 149.28
EBITDA margin %
-813.03
-371.07
-267.26
-215.88
-250.6
-1 104.81
Net margin %
-682.88
-316.43
-237.34
-194.39
-234.28
-982.45
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
3.73
3.16
2.62
2.16
2.73
10.68
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0.02
0.03
0.04
0.05
0.14
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.45
-0.38
-0.33
-0.3
-0.35
-1.37
EBIT per share
-0.44
-0.36
-0.33
-0.29
-0.38
-1.37
EBITDA per share
-0.42
-0.35
-0.32
-0.28
-0.37
-1.32
Total debt per share
—
—
—
—
—
—
Cash per share
1.01
0.97
1.15
1.42
1.28
4.82
Net current asset value per share
4.55
3.59
3.24
2.92
2.59
12.34
Tangible book value per share
-0.83
-0.98
-1.22
-1.42
-1.72
-5.34
Working capital per share
3.33
2.45
2
1.57
1.64
7.67
Book value per share
-0.83
-0.98
-1.22
-1.42
-1.72
-5.34
Nouvelles
Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength?
Citizens réitère sa recommandation sur Foghorn Therapeutics après les progrès du pipeline
Citizens reiterates Foghorn Therapeutics stock rating on pipeline progress
Jefferies réitère sa recommandation sur Foghorn Therapeutics après des données sur le pipeline
Jefferies reiterates Foghorn Therapeutics stock rating on pipeline data
Stifel réitère sa recommandation d’achat sur Foghorn Therapeutics
Stifel reiterates Foghorn Therapeutics stock rating at buy
Le BPA de Foghorn a manqué les attentes de 0,02$, le CA en dessous des prévisions
Foghorn earnings missed by $0.02, revenue fell short of estimates
Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Beats Revenue Estimates
Foghorn Therapeutics annonce une trésorerie de 158,9 M$ et prolonge sa visibilité financière
Foghorn Therapeutics reports $158.9M cash position, extends runway